(ZTS)
NYQ – Real Time Price. Currency in USD
113.35
-3.28 (-2.81%)
At close: Mar 27, 2026, 4:03 PM EDT
113.20
-0.15 (-0.13%)
After-hours: Mar 27, 2026, 7:57 PM EDT
Get all premium features to the best stock analysis tool
NYQ – Real Time Price. Currency in USD
113.35
-3.28 (-2.81%)
At close: Mar 27, 2026, 4:03 PM EDT
113.20
-0.15 (-0.13%)
After-hours: Mar 27, 2026, 7:57 PM EDT
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
| Name | Position |
|---|---|
| Dr. Robert J. Polzer Ph.D. | Scientific Advisor |
| Mr. Jamie Brannan | Executive VP & Chief Commercial Officer |
| Mr. Keith Sarbaugh | Executive VP & Chief Digital and Technology Officer |
| Mr. Nick Ashton | Executive VP and President of Global Manufacturing & Supply |
| Mr. Steven Frank | Vice President of Investor Relations |
| Mr. Wetteny N. Joseph CPA | Executive VP & CFO |
| Ms. Jeannette Ferran Astorga | Executive VP of Corporate Affairs & Chief Sustainability Officer |
| Date | Type | Document |
|---|---|---|
| 2025-12-18 | 8-K | d35588d8k.htm |
| 2025-12-11 | 8-K | zts-20251211.htm |
| 2025-12-02 | 8-K | zts-20251202.htm |
| 2025-11-04 | 8-K | zts-20251104.htm |
| 2025-10-28 | 8-K | zts-20251023.htm |
| 2025-10-09 | 8-K | zts-20251009.htm |
| 2025-08-27 | 8-K | d24666d8k.htm |
| 2025-08-18 | 8-K | d899078d8k.htm |
| 2025-08-05 | S-3ASR | d92874ds3asr.htm |
| 2025-06-23 | 11-K | zoetis202411-ksavingsplan.htm |
| Ms. Julie A. Fuller |
| Executive VP, Chief Human Resources Officer & Global Operations |
| Ms. Kristin C. Peck | CEO & Director |
| Ms. Roxanne Lagano | Executive VP, General Counsel & Corporate Secretary |